Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

ANTHONY T INZERELLO

Allopathic & Osteopathic Physicians Family Medicine

NPI
1821175092
CMS profile
174035
Location
EVANSVILLE, IN

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2022 · Entire year

$19,317.26

71 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2022 · entire year · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $18,480.00 12
Food and Beverage $837.26 59

By paying entity

PY2022 · entire year · sorted by reported total

Page 2 of 2; records 51–71 of 71 matching records. This page contains 21 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

ANTHONY T INZERELLO

NPI 1821175092 · CMS profile ID 174035

Allopathic & Osteopathic Physicians / Family Medicine

EVANSVILLE, IN

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 2; records 51–71 of 71 matching records. This page contains 21 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1821175092?year=2022&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
ANTHONY T INZERELLO, NPI 1821175092, CMS profile ID 174035. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–71 of 71 matching records. This page contains 21 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1821175092?year=2022&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
APA 7
IndustryPayments. (2026). ANTHONY T INZERELLO, NPI 1821175092, CMS profile ID 174035. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–71 of 71 matching records. This page contains 21 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1821175092?year=2022&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
Bluebook
ANTHONY T INZERELLO, NPI 1821175092, CMS profile ID 174035, IndustryPayments, General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 2; records 51–71 of 71 matching records. This page contains 21 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c. https://industrypayments.org/provider/npi-1821175092?year=2022&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2022 · Physicians and non-physician practitioners · CMS publication 2026-06-30

71 matching records · $19,317.26 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 71 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–71 of 71.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Janssen Pharmaceuticals, Inc $12.2305/26/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 886206193 CMS
Takeda Pharmaceuticals U.S.A., Inc. $15.3905/19/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 955663685 CMS
AstraZeneca Pharmaceuticals LP $12.1505/16/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 915277279 CMS
ABBVIE INC. $14.2205/13/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 892890073 CMS
Amgen Inc. $4.0705/13/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939203451 CMS
CSL Behring $1,680.0005/11/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 940906009 CMS
CSL Behring $1,680.0005/11/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 940906257 CMS
Novo Nordisk Inc $15.0805/09/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 898691689 CMS
Novo Nordisk Inc $13.9405/08/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 899269071 CMS
Takeda Pharmaceuticals U.S.A., Inc. $16.1604/28/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 955663681 CMS
Janssen Pharmaceuticals, Inc $11.6804/26/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 886206187 CMS
Otsuka America Pharmaceutical, Inc. $16.4104/18/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 929295455 CMS
Merck Sharp & Dohme LLC $13.7504/11/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944776901 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $13.6704/07/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 887334401 CMS
CSL Behring $1,680.0003/07/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 940905931 CMS
CSL Behring $1,680.0003/07/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 940905935 CMS
Otsuka America Pharmaceutical, Inc. $17.1903/01/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 929295453 CMS
AstraZeneca Pharmaceuticals LP $12.1202/11/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 915039751 CMS
Otsuka America Pharmaceutical, Inc. $16.6001/18/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 929295451 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $12.9101/11/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 887676993 CMS
Novo Nordisk Inc $13.6801/07/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 898691683 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $37,951.41 188
PY2020 $32,632.40 52
PY2021 $33,814.81 60
PY2022 $19,317.26 71
PY2023 $75,946.59 109
PY2024 $55,952.74 76
PY2025 $52,570.57 96

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2019 Principal investigator $29,841.29 14

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2019

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

14 records in PY2019

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 AstraZeneca UK Limited $421.30 12/31/2019 Non-covered Recipient Entity
Clinical Research Advantage Inc
A Long Term Outcomes Study to Assess STatin Residual Risk Reduction with EpaNova in HiGh Cardiovascular Risk PatienTs with Hypertriglyceridemia No dispute reported 06/30/2026 684999655
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $1,050.00 11/06/2019 Non-covered Recipient Entity
SYNEXUS US
A PHASE 3 RANDOMIZED, DOUBLE-BLIND, MULTI-DOSE, PLACEBO-CONTROLLED STUDY TO EVALUATE THE LONG-TERM SAFETY AND THE EFFICACY OF FASINUMAB IN PATIENTS WITH PAIN DUE TO OSTEOARTHRITIS OF THE KNEE OR HIP No dispute reported 06/30/2026 639737981
Principal investigator 1 Kowa Research Institute, Inc. $1,858.20 05/06/2019 Non-covered Recipient Entity
CLINICAL RESEARCH ADVANTAGE INC
K-877-302 No dispute reported 06/30/2026 629128705
Principal investigator 1 Kowa Research Institute, Inc. $256.00 05/02/2019 Non-covered Recipient Entity
CLINICAL RESEARCH ADVANTAGE INC
K-877-302 No dispute reported 06/30/2026 629128703
Principal investigator 1 AstraZeneca Pharmaceuticals LP $225.00 04/23/2019 Non-covered Recipient Entity
Clinical Research Advantage Inc.
A Phase IIb Randomised Parallel Double Blind Placebo Controlled and Open Label Active Comparator Study to Evaluate the Efficacy and Safety of MEDI0382 in the Treatment of Overweight and Obese Subjects with Type 2 Diabetes Mellitus No dispute reported 06/30/2026 684977479
Principal investigator 1 Kowa Research Institute, Inc. $256.00 04/10/2019 Non-covered Recipient Entity
CLINICAL RESEARCH ADVANTAGE INC
K-877-302 No dispute reported 06/30/2026 629128699
Principal investigator 1 AstraZeneca UK Limited $2,654.20 03/19/2019 Non-covered Recipient Entity
Clinical Research Advantage Inc
A Long Term Outcomes Study to Assess STatin Residual Risk Reduction with EpaNova in HiGh Cardiovascular Risk PatienTs with Hypertriglyceridemia No dispute reported 06/30/2026 684999587
Principal investigator 1 Kowa Research Institute, Inc. $256.00 03/19/2019 Non-covered Recipient Entity
CLINICAL RESEARCH ADVANTAGE INC
K-877-302 No dispute reported 06/30/2026 629128587
Principal investigator 1 AstraZeneca Pharmaceuticals LP $6,474.39 03/14/2019 Non-covered Recipient Entity
Clinical Research Advantage Inc
A Phase IIb Randomised Parallel Double Blind Placebo Controlled and Open Label Active Comparator Study to Evaluate the Efficacy and Safety of MEDI0382 in the Treatment of Overweight and Obese Subjects with Type 2 Diabetes Mellitus No dispute reported 06/30/2026 684977338
Principal investigator 1 Kowa Research Institute, Inc. $256.00 03/05/2019 Non-covered Recipient Entity
CLINICAL RESEARCH ADVANTAGE INC
K-877-302 No dispute reported 06/30/2026 629128589
Principal investigator 1 Kowa Research Institute, Inc. $235.60 02/07/2019 Non-covered Recipient Entity
CLINICAL RESEARCH ADVANTAGE INC
K-877-302 No dispute reported 06/30/2026 629128585
Principal investigator 1 Kowa Research Institute, Inc. $1,200.80 01/21/2019 Non-covered Recipient Entity
CLINICAL RESEARCH ADVANTAGE INC
K-877-302 No dispute reported 06/30/2026 629128591
Principal investigator 1 Kowa Research Institute, Inc. $256.00 01/11/2019 Non-covered Recipient Entity
CLINICAL RESEARCH ADVANTAGE INC
K-877-302 No dispute reported 06/30/2026 629128593
Principal investigator 1 AstraZeneca Pharmaceuticals LP $14,441.80 01/08/2019 Non-covered Recipient Entity
Clinical Research Advantage Inc
Dapagliflozin Effect on Cardiovascular Events A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Effect of Dapagliflozin 10 mg Once Daily on the Incidence of Cardiovascular Death, Myocardial Infarction or Ischemic Stroke in Patients with Type 2 Diabetes No dispute reported 06/30/2026 684977343